共 50 条
- [33] Dolutegravir for second-line antiretroviral therapy: the beat goes on LANCET GLOBAL HEALTH, 2024, 12 (02): : E183 - E184
- [36] Tenofovir resistance and first-line antiretroviral therapy LANCET INFECTIOUS DISEASES, 2016, 16 (08): : 890 - 891